Skip to content

HIV-2 does not protect against HIV-1 infection

Enteric-coated ddI: UK named patient scheme begins

Activists demand rapid access to ABT-378

Norvir™ Soft Elastic Capsule named patient programme

Abacavir: take care when re-starting

Six new UK trials start in March

Vancouver set back AIDS drug development ''two or three years''

When to start: viral load less important than CD4 count

HIV risk from single contact may be higher than thought

HIV sceptics appointed to South African AIDS panel

Salvage therapy workshop: full reports

Agents found to attack two new steps in HIV life cycle

Bottle feeding cuts HIV risk for babies

Cmin or Cspin? Why drug levels are the new battleground for pharma cos

European AIDS death rates plummet

Viral load and disease progression risks may differ in men and women

Body fat changes on HIV therapy: a new theory

First line d4T/ddI treatment means AZT resistance for some